Hanmi Pharmaceutical (South Korea)

416 papers and 6.1k indexed citations i.

About

In recent decades, authors affiliated with Hanmi Pharmaceutical (South Korea) have published 416 papers, which have received a total of 6.1k indexed citations. Scholars at this organization have produced 93 papers in Oncology, 91 papers in Molecular Biology and 61 papers in Surgery on the topics of Diabetes Treatment and Management (32 papers), HER2/EGFR in Cancer Research (27 papers) and Drug Solubulity and Delivery Systems (26 papers). Their work is cited by papers focused on Molecular Biology (1.8k citations), Oncology (1.2k citations) and Pharmaceutical Science (997 citations). Authors at Hanmi Pharmaceutical (South Korea) collaborate with scholars in South Korea, United States and Canada and have published in prestigious journals including Circulation, Nature Communications and Journal of Clinical Oncology. Some of Hanmi Pharmaceutical (South Korea)'s most productive authors include Srinivasan Shanmugam, Jong Soo Woo, Sung‐Joo Hwang, Dae‐Sung Kyoung, Gwan Sun Lee, Sibeum Lee, Jong-Soo Woo, Hun‐Sung Kim, Maeng Sup Kim and Jae Yong Han.

In The Last Decade

Fields of papers published by authors at Hanmi Pharmaceutical (South Korea)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Hanmi Pharmaceutical (South Korea) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Hanmi Pharmaceutical (South Korea) at the time of their publication.

Countries citing scholars working at Hanmi Pharmaceutical (South Korea)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Hanmi Pharmaceutical (South Korea). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Hanmi Pharmaceutical (South Korea) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanmi Pharmaceutical (South Korea) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025